Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
15.78
0.00 (0.00%)
At close: Feb 26, 2026, 4:00 PM EST
15.78
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:00 PM EST

Contineum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21
570378---
Enterprise Value
391164---
Last Close Price
15.7814.65---
PB Ratio
2.551.91---
P/TBV Ratio
3.151.91---
Debt / Equity Ratio
0.030.030.010.150.08
Debt / EBITDA Ratio
--0.03--
Debt / FCF Ratio
--0.03--
Net Debt / Equity Ratio
-0.98-1.00-1.00-1.05-1.04
Net Debt / EBITDA Ratio
2.613.92-7.661.852.26
Net Debt / FCF Ratio
3.355.95-6.582.052.42
Asset Turnover
--0.55--
Quick Ratio
28.6820.5322.836.2618.78
Current Ratio
29.0720.6923.296.4118.99
Return on Equity (ROE)
-30.40%-26.19%27.71%-48.09%-
Return on Assets (ROA)
-20.89%-18.54%11.10%-23.44%-
Return on Capital Employed (ROCE)
-36.90%-25.10%12.90%-52.70%-42.90%
Earnings Yield
-10.45%-11.19%---
FCF Yield
-9.30%-8.83%---
Buyback Yield / Dilution
-96.27%-469.95%-51.38%-6.35%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q